drugset / Trial / NCT00345982

Augmenting Clozapine With Sertindole - SERCLOZ

NCT00345982

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine whether addition of sertindole to clozapine treatment can improve psychosis or the metabolic side-effects of clozapine in patients with treatment-resistant schizophrenia.

Timeline

Start
2006-09
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertindole Small molecule 16 mg

Indications